Clinical trial
Effect of Cladribine Treatment on Microglial Activation in the CNS
NCT04239820 · Turku University Hospital, Other · Active, not recruiting
Key facts
| NCT number | NCT04239820 |
|---|---|
| Title | Effect of Cladribine Treatment on Microglial Activation in the CNS |
| Official title | Effect of Cladribine Treatment on Microglial Activation in the CNS |
| Acronym | CLADPET |
| Lead sponsor | Turku University Hospital, Other |
| Status | Active, not recruiting |
| Study type | Observational |
| Conditions | Multiple Sclerosis |
| Intervention type | Radiation |
| Interventions | Imaging |
| Enrollment | 15 |
| Start date | Jan 10, 2020 |
| Primary completion | Feb 15, 2024 |
| Completion | Dec 1, 2025 |
| First posted | Jan 27, 2020 |
| Last update posted | Jan 15, 2025 |
| Countries | Finland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: